Search Results
Search for other papers by Darren Cowzer in
Google Scholar
PubMed
Search for other papers by Ronak H Shah in
Google Scholar
PubMed
Search for other papers by Joanne F Chou in
Google Scholar
PubMed
Search for other papers by Ritika Kundra in
Google Scholar
PubMed
Search for other papers by Sippy Punn in
Google Scholar
PubMed
Search for other papers by Laura Fiedler in
Google Scholar
PubMed
Search for other papers by April DeMore in
Google Scholar
PubMed
Search for other papers by Marinela Capanu in
Google Scholar
PubMed
Department of Pathology and laboratory medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Search for other papers by Michael F Berger in
Google Scholar
PubMed
Weill Medical College of Cornell University, New York, New York, USA
Search for other papers by Diane Reidy-Lagunes in
Google Scholar
PubMed
Weill Medical College of Cornell University, New York, New York, USA
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (panNENs) represent a heterogenous group of tumors with varying clinical behaviors and outcomes with increasing incidence and prevalence ( Dasari et al. 2017 ). Tumors are histologically
Department of Oncology, Haukeland University Hospital, Bergen, Norway
Search for other papers by Andreas Venizelos in
Google Scholar
PubMed
Department of Clinical Science, University of Bergen, Bergen, Norway
Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Search for other papers by Hege Elvebakken in
Google Scholar
PubMed
Search for other papers by Aurel Perren in
Google Scholar
PubMed
Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed
Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed
Department of Medical Radiation Physics, Lund University, Lund, Sweden
Search for other papers by Anna Sundlöv in
Google Scholar
PubMed
Search for other papers by Johanna Svensson in
Google Scholar
PubMed
Search for other papers by Harrish Garresori in
Google Scholar
PubMed
Search for other papers by Christian Kersten in
Google Scholar
PubMed
Department of Oncology, St. Olavs Hospital, Trondheim, Norway
Search for other papers by Eva Hofsli in
Google Scholar
PubMed
Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed
Search for other papers by Lene W Vestermark in
Google Scholar
PubMed
Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Morten Ladekarl in
Google Scholar
PubMed
Search for other papers by Elizaveta Mitkina Tabaksblat in
Google Scholar
PubMed
Department of Oncology, Haukeland University Hospital, Bergen, Norway
Search for other papers by Stian Knappskog in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) constitute ~2% of all malignancies and are frequently located in the gastrointestinal (GI) tract and pancreas. High-grade gastroenteropancreatic (HG-GEP) NENs are among the most aggressive cancers
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
ICBAS – Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Search for other papers by Tiago Bordeira Gaspar in
Google Scholar
PubMed
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Department of Pathology, Centro Hospitalar e Universitário de São João, Porto, Portugal
Search for other papers by José Manuel Lopes in
Google Scholar
PubMed
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Search for other papers by João Vinagre in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (PanNENs) are rare entities that constitute the second most common pancreatic malignancy (1–2% of all pancreatic neoplasms) following pancreatic ductal adenocarcinoma (PDAC) ( Lawrence et al
Section of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
Search for other papers by T Vandamme in
Google Scholar
PubMed
Search for other papers by M Beyens in
Google Scholar
PubMed
Search for other papers by G Boons in
Google Scholar
PubMed
Search for other papers by A Schepers in
Google Scholar
PubMed
Search for other papers by K Kamp in
Google Scholar
PubMed
Search for other papers by K Biermann in
Google Scholar
PubMed
Search for other papers by P Pauwels in
Google Scholar
PubMed
Search for other papers by W W De Herder in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by M Peeters in
Google Scholar
PubMed
Search for other papers by G Van Camp in
Google Scholar
PubMed
Search for other papers by K Op de Beeck in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms of the pancreas (pNENs), originating from the islet cells, are considered rare, although incidence is increasing ( Dasari et al . 2017 ). pNENs can occur as part of genetic syndromes, such as multiple
Search for other papers by Jennifer R Eads in
Google Scholar
PubMed
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
Search for other papers by Tim Asmis in
Google Scholar
PubMed
Search for other papers by Andrew M Bellizzi in
Google Scholar
PubMed
Search for other papers by Emily K Bergsland in
Google Scholar
PubMed
Search for other papers by Arvind Dasari in
Google Scholar
PubMed
Search for other papers by Ghassan El-Haddad in
Google Scholar
PubMed
Search for other papers by Michael Frumovitz in
Google Scholar
PubMed
Search for other papers by Joshua Meyer in
Google Scholar
PubMed
Search for other papers by Erik Mittra in
Google Scholar
PubMed
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
Search for other papers by Eric Nakakura in
Google Scholar
PubMed
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Search for other papers by Heloisa P Soares in
Google Scholar
PubMed
Search for other papers by Brian Untch in
Google Scholar
PubMed
Search for other papers by Namrata Vijayvergia in
Google Scholar
PubMed
Search for other papers by Jennifer A Chan in
Google Scholar
PubMed
Introduction High-grade neuroendocrine neoplasms (NENs) constitute a rare disease entity and account for approximately 10% of all NENs. Given their rarity, there is a paucity of prospective data to guide the optimal diagnosis and management of
Search for other papers by Giulia Vocino Trucco in
Google Scholar
PubMed
Search for other papers by Marco Volante in
Google Scholar
PubMed
Introduction: a universal terminology and classification system The World Health Organization (WHO) has recently introduced a universal classification framework for neuroendocrine neoplasms (NENs), proposing a single model for terminology and
Search for other papers by Shani Avniel-Polak in
Google Scholar
PubMed
Search for other papers by Gil Leibowitz in
Google Scholar
PubMed
Search for other papers by Victoria Doviner in
Google Scholar
PubMed
Search for other papers by David J Gross in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) constitute a heterogeneous and rare family of tumors that arise from cells of the diffuse endocrine system dispersed throughout the body, with an increasing annual incidence (~6.9/100,000 people
Search for other papers by Roberto Valente in
Google Scholar
PubMed
Search for other papers by Alastair J Hayes in
Google Scholar
PubMed
Search for other papers by Sven-Petter Haugvik in
Google Scholar
PubMed
Search for other papers by Per Hedenström in
Google Scholar
PubMed
Search for other papers by Darko Siuka in
Google Scholar
PubMed
Search for other papers by Emilie Korsæth in
Google Scholar
PubMed
Search for other papers by Daniel Kämmerer in
Google Scholar
PubMed
Search for other papers by Stuart M Robinson in
Google Scholar
PubMed
Search for other papers by Patrick Maisonneuve in
Google Scholar
PubMed
Search for other papers by Gianfranco Delle Fave in
Google Scholar
PubMed
Search for other papers by Bjorn Lindkvist in
Google Scholar
PubMed
Search for other papers by Gabriele Capurso in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (PNENs) are a group of tumors which originate from endocrine cells within the pancreas gland. PNENs have heterogeneous clinical behavior owing to their hormone functional status, cellular
Search for other papers by James C Yao in
Google Scholar
PubMed
Search for other papers by Jonathan Strosberg in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Search for other papers by Emily Bergsland in
Google Scholar
PubMed
Search for other papers by Philippe Ruszniewski in
Google Scholar
PubMed
Search for other papers by Daniel M Halperin in
Google Scholar
PubMed
Search for other papers by Daneng Li in
Google Scholar
PubMed
Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Search for other papers by Davide Campana in
Google Scholar
PubMed
Search for other papers by Susumu Hijioka in
Google Scholar
PubMed
Search for other papers by Markus Raderer in
Google Scholar
PubMed
Search for other papers by Rosine Guimbaud in
Google Scholar
PubMed
Search for other papers by Pablo Gajate in
Google Scholar
PubMed
Search for other papers by Sara Pusceddu in
Google Scholar
PubMed
Search for other papers by Albert Reising in
Google Scholar
PubMed
Search for other papers by Evgeny Degtyarev in
Google Scholar
PubMed
Search for other papers by Mark Shilkrut in
Google Scholar
PubMed
Search for other papers by Simantini Eddy in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
years ( Yao et al. 2008 ). Neuroendocrine neoplasms (NENs) are comprised of well-differentiated NETs and poorly differentiated neuroendocrine carcinomas (NECs). The World Health Organization classification reported four categories, based on tumor
Search for other papers by Chiara Borga in
Google Scholar
PubMed
Search for other papers by Carlo Alberto Dal Pozzo in
Google Scholar
PubMed
Search for other papers by Elisabetta Trevellin in
Google Scholar
PubMed
Search for other papers by Francesca Bergamo in
Google Scholar
PubMed
Search for other papers by Sabina Murgioni in
Google Scholar
PubMed
Search for other papers by Anna Caterina Milanetto in
Google Scholar
PubMed
Search for other papers by Claudio Pasquali in
Google Scholar
PubMed
Search for other papers by Umberto Cillo in
Google Scholar
PubMed
Search for other papers by Giada Munari in
Google Scholar
PubMed
Search for other papers by Chiara Martini in
Google Scholar
PubMed
Search for other papers by Eugenio De Carlo in
Google Scholar
PubMed
Search for other papers by Vittorina Zagonel in
Google Scholar
PubMed
Search for other papers by Vincenza Guzzardo in
Google Scholar
PubMed
Search for other papers by Gianmaria Pennelli in
Google Scholar
PubMed
Search for other papers by Angelo Paolo Dei Tos in
Google Scholar
PubMed
Search for other papers by Roberto Vettor in
Google Scholar
PubMed
Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
Search for other papers by Matteo Fassan in
Google Scholar
PubMed
Introduction Gastrointestinal neuroendocrine neoplasms (GI-NENs) are a heterogeneous group of malignancies that represent an emerging issue both in research and clinical practice due to their increase in incidence ( Patel & Benipal 2019 ) and